Department of Health written question – answered at on 13 November 2014.
Liz Kendall
Shadow Minister (Health) (Care and Older People)
To ask the Secretary of State for Health, how much the Government has spent on the development of new drugs to treat the symptoms of asthma in each of the last five years.
George Freeman
The Parliamentary Under-Secretary of State for Business, Innovation and Skills, The Parliamentary Under-Secretary of State for Health
The correct answer should have been:
The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.
£ million
2009-10 | 2010-11 | 2011-12 | 2012-13 | 2013-14 | |
Asthma | |||||
Medical Research Council |
|
|
|
|
|
Other Research Councils and Innovate UK | 0.0 | 0.1 | 0.3 | 1.5 | 0.8 |
National Institute for Health Research | 2.6 | 3.4 | 2.4 | 3.4 | 3.8 |
Total |
|
|
|
|
|
Motor Neurone Research | |||||
Medical Research Council | 7.0 | 7.5 | 4.2 | 4.1 | 3.6 |
Other Research Councils and Innovate UK | 0.2 | 0.2 | 0.4 | 0.7 | 1.0 |
National Institute for Health Research | 0.1 | 0.1 | 0.4 | 0.7 | 0.5 |
Total | 7.3 | 7.8 | 5.0 | 5.5 | 5.1 |
Osteoporosis | |||||
Medical Research Council | 6.2 | 5.4 | 5.1 | 4.6 | 5.9 |
Other Research Councils and Innovate UK | 0.0 | 0.0 | 0.1 | 0.4 | 1.0 |
National Institute for Health Research | 0.3 | 0.7 | 0.8 | 1.3 | 1.8 |
Total | 6.5 | 6.1 | 6.0 | 6.3 | 8.7 |
The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.
Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.
Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.
Yes3 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.
George Freeman
The Parliamentary Under-Secretary of State for Business, Innovation and Skills, The Parliamentary Under-Secretary of State for Health
The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.
£ million
2009-10 | 2010-11 | 2011-12 | 2012-13 | 2013-14 | |
Asthma | |||||
Medical Research Council |
|
|
|
|
|
Other Research Councils and Innovate UK | 0.0 | 0.1 | 0.3 | 1.5 | 0.8 |
National Institute for Health Research | 2.6 | 3.4 | 2.4 | 3.4 | 3.8 |
Total |
|
|
|
|
|
Motor Neurone Research | |||||
Medical Research Council | 7.0 | 7.5 | 4.2 | 4.1 | 3.6 |
Other Research Councils and Innovate UK | 0.2 | 0.2 | 0.4 | 0.7 | 1.0 |
National Institute for Health Research | 0.1 | 0.1 | 0.4 | 0.7 | 0.5 |
Total | 7.3 | 7.8 | 5.0 | 5.5 | 5.1 |
Osteoporosis | |||||
Medical Research Council | 6.2 | 5.4 | 5.1 | 4.6 | 5.9 |
Other Research Councils and Innovate UK | 0.0 | 0.0 | 0.1 | 0.4 | 1.0 |
National Institute for Health Research | 0.3 | 0.7 | 0.8 | 1.3 | 1.8 |
Total | 6.5 | 6.1 | 6.0 | 6.3 | 8.7 |
The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.
Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.
Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.
Yes2 people think so
No0 people think not
Would you like to ask a question like this yourself? Use our Freedom of Information site.
Secretary of State was originally the title given to the two officials who conducted the Royal Correspondence under Elizabeth I. Now it is the title held by some of the more important Government Ministers, for example the Secretary of State for Foreign Affairs.
